Brief: 180 Life Sciences Corp. Announces Collection Of All Patient Data For Phase 2B Dupuytren’S Disease Trial
20/04/2021 13:10
April 20 (Reuters) - 180 Life Sciences Corp ATNF.O :
* 180 LIFE SCIENCES CORP. ANNOUNCES COLLECTION OF ALL
PATIENT DATA
FOR PHASE 2B DUPUYTREN’S DISEASE TRIAL
Source text for Eikon: ID:nGNX4S5Xsj
Further company coverage: ATNF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Forum Markets,
See all newsBrief: Forum Markets, Inc - To Deploy Capital Into Ai Chip Bridge Loans For Nvidia Gpu Purchases
Brief: Forum Reports Fourth Quarter And Full Year 2025 Financial Results
Brief: Ethzilla Announces First Ever Tradable Tokenized Aviation Assets On Ethereum Network
Brief: ETHZilla - On January 17 Buys Two CFM56-7B24 Aircraft Engines - SEC Filing
Brief: Ethzilla Appoints Angela Dalton And Michael Edwards To Board Of Directors